Alcon AG banner

Intrinsic Value

The intrinsic value of Alcon AG (2U3) under the Base Case is EUR per share. Compared with the current market price of 67.02 EUR, the stock appears .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

2U3 Intrinsic Value

What one share is worth in the bear, base and bull cases.

Create a free account · No card needed

Do our valuations actually work? See backtest results .

Alert me when 2U3 is below its intrinsic value
Today Hidden ·
2U3 Valuation History

Intrinsic value next to the price over the past 11 months.

Create a free account · No card needed

Alternatives to 2U3

Fundamental Analysis

What Alcon Does

Health Care

Alcon AG is a global eye-care company that makes products used to treat, correct, and care for vision. Its main business is split between surgical eye care and vision care. In surgery, it sells equipment, disposable tools, and implants that eye surgeons use in procedures such as cataract and retinal surgery. In vision care, it sells contact lenses, lens-care products, and other items for everyday eye health.

Headquarters
Switzerland CH
Employees
25 000
IPO date
Apr 9, 2019
Read the full company overview
View Company Overview

Alcon has a narrow economic moat

No Moat Narrow Wide

Replacing Alcon’s surgical equipment means buying new machines and teaching surgical teams to use them, making a cheaper rival less attractive. Patents on contact lens materials and implanted lens designs also make it harder for competitors to copy important product features.

Read the full moat analysis
Financials
Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Continue 2U3 Research

Decided on Alcon? Get an email when 2U3 reaches the price you’d buy at. Free with an account.

What is the Intrinsic Value of one 2U3 stock?

The intrinsic value for Alcon AG (2U3) under the Base Case is EUR.

Is 2U3 stock undervalued or overvalued?

Compared with the current market price of 67.02 EUR, the stock appears .

How reliable are our estimates? See how past valuations played out
Back to Top